ArticleBMJ open gastroenterology2023

First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan.

Kota Tsuruya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.